William Andrew Macan - Dec 19, 2023 Form 4 Insider Report for Neuronetics, Inc. (STIM)

Role
EVP, GC, CCO and CS
Signature
/s/ W. Andrew Macan
Stock symbol
STIM
Transactions as of
Dec 19, 2023
Transactions value $
-$87,011
Form type
4
Date filed
12/21/2023, 07:42 PM
Previous filing
Oct 10, 2023
Next filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STIM Common Stock Sale -$26.1K -11.7K -3.04% $2.24 372K Dec 19, 2023 Direct F1, F2
transaction STIM Common Stock Sale -$31.5K -11.7K -3.13% $2.70 360K Dec 20, 2023 Direct F1, F3
transaction STIM Common Stock Sale -$29.4K -11.7K -3.24% $2.52 349K Dec 21, 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.13 to $2.50. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.42 to $2.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.46 to $2.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.